New hope for tough cancers: experimental drug targets rare sarcomas
Disease control
Recruiting now
This early-stage study is testing whether a new drug called BTX-A51 is safe for people with advanced liposarcoma, a rare type of cancer. Researchers will give the drug to about 24 patients whose cancer has returned or spread, and monitor them closely for side effects. The study w…
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC